MedPath
NMPA Approval

Oxybuprocaine Hydrochloride Eye Drops

国药准字H20249589

December 1, 2024

Drug Information

盐酸奥布卡因滴眼液

眼用制剂

0.4%(0.5ml:2mg)

化学药品

December 1, 2024

Company Information

Applicant Company

苏州市吴中区郭巷街道尹中南路1858号

Manufacturing Company

苏州市吴中区郭巷街道尹中南路1858号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥布卡因滴眼液 - NMPA 批准文号 | MedPath